|
February 1st, 2001, two studies published in the magazine American "New England newspaper "Medicine of seem to exonerate the vaccine of the B hepatitis, accused of can drag the apparition of case of multiple sclerosis or the aggravation of the illness already at people attacks, completely. Point final or new episode of this polemic? In May 2000, the debate had been thrown back by the indemnification of some patients by the public powers that implicitly recognized for the first time a tie. May 15, 2000, the general Direction of health (DGS) sent an opinion of recognition to eight people, of which three are reached of multiple sclerosis. These letters opened right thus to an indemnification. According to the edition of the Parisian of May 25, 2000 one of this mail, signed by Professor Lucien Abenhaïm, director of the DGS, exposes that - within sight of the last data of pharmacovigilance and epidemiological, communicated by the French agency of sanitary security of the health products and within sight of your file , a tie of causality existed between the vaccination B hepatitis and your state of health." The Code of the public health plans a particular procedure for the damages bound to the obligatory vaccinations. This dependent commission of the Health ministry, don't manage as well as the staffs of health; only these last have an obligation of vaccination against the B. hepatitis For the rest of the population, it is recommended merely. Thus, the essential of the victims supposed doesn't have access to this commission and doesn't have any other recourses that to turn toward the courts. An ambiguous attitude.Since 1991, six decisions of indemnification for neurological affections or rhumatologiques have already been taken, but it was the first time that one of her concerns multiple sclerosis. Annoyed of this initiative, the Secretariat of state to Health and to Disabled publishes a press release in the evening May 25, 2000 that specifies that "this decision has been taken in the interest of the sick person, even if the experts (.) could not conclude until now, on the existence of an association between this vaccination and the intervening of a multiple sclerosis or auto-immune affections. These experts had estimated however that a weak risk of tie between the vaccine against the B hepatitis and these affections could not be excluded in the present state of the knowledge." Excess of prudence, Norman French answer. the sanitary authorities wait for the science an opinion that it doesn't seem currently in measure to give. Of the studies exonerating the vaccineToday no tie has been proven between the vaccination against the B hepatitis and the intervening of neurological unrests. Interrogated on this topic whereas it presented these works on the clarification of a vaccine to DNA against the B hepatitis, Christian Bréchot that was part of the meeting of September 1998 experts, said itself personally since May 2000 very skeptic on any relation of causality. "No tie has can be established ever between the vaccine against the B hepatitis and the intervening of multiple sclerosis. The last independent survey on this topic appeared in Nature Medicine concludes to the absence of relations." February 1st, 2001, the prestigious magazine the New England newspaper "Medicine of published two studies: one European conduct on 600 patients and the other American driven on 230 000 nurses. The first studied the risk of intervening of new advanced of sclerosis in plate at patients following vaccinations (B hepatitis but as tetanus, poliomyelitis, diphtheria, flu.). The authors conclude that no increase of the risk of thrust fasaint following a vaccination. Conducted to bigger scale, the second survey aimed to determine the risk of intervening of case of multiple sclerosis among healthy subjects. There the findings seem again, categorical: no association between the vaccination against the B hepatitis and the risk of intervening of sclerosis. These two studies have been financed by laboratories manufacturer of the vaccines. Nevertheless, the researchers assure to have benefitted beforehand from the engagement writes their financeurs to be able to publish their results whatever they are. No discount in reason of the vaccinal politicsThe sanitary authorities continue to recommend the vaccination. The communiqué concludes: "These decisions don't question the assessment of the profit again risks the vaccine against the B hepatitis and the recommendations concerning vaccinal politics." The B hepatitis remains the reason of near 1 000 deaths every year in France and no new argument questions the strategies of vaccination again (source Secretariat of state to Health and to the Social action): - The vaccination obligatory of the staffs of health expositions to a risk of contamination by the virus of the B hepatitis;
- The recommendation of vaccination of people that presents individual risks of contamination by the virus of the B hepatitis, either according to their behaviors (users of drug venous intra, multiple sexual partners and non protected reports), either according to a particular exhibition (because of a treatment, of a professional activity, of journey in zone of strong endemic.), as they are indicated in the vaccinal calendar of 1999;
- The vaccination of the infants in the first year of life remains advisable.
At the time of the announcement of the plan triennial "hepatitises" of February 2002, the Minister delegated in the Health Bernard Kouchner was anxious to recall the very good efficiency of the vaccine. Concerning the controversy on a possible tie with the apparition of neurological illnesses, as multiple sclerosis, he/it underlined that a new appraisal driven by the Pr. Dartigues should specify the vaccinal indications shortly. 2009-03-04
|
